The U.S. Food and Drug Administration (FDA) has announced a Class I recall, its most serious recall category, for certain Medtronic Harmony™ Delivery Catheter Systems (DCS) used to implant transcatheter pulmonary valves. The recall follows concerns that a manufacturing defect could cause the catheter's distal tip to detach during implantation, potentially leading to serious complications, including emergency surgery or death.
The affected device is the Harmony™ Delivery Catheter System, which is used to deliver the Harmony™ Transcatheter Pulmonary Valve (TPV) in patients with congenital heart disease requiring pulmonary valve replacement. According to the FDA, devices manufactured from specific production lots contain inner shaft assemblies that may have an increased risk of distal tip detachment under certain procedural or anatomical conditions because of a manufacturing issue.
If the catheter tip separates during the procedure, it may become lodged within the patient's cardiovascular system. This could result in prolonged procedures, vascular injury, additional catheter-based retrieval procedures, emergency open-heart surgery, or, in rare cases, life-threatening outcomes. The FDA classified the action as a Class I recall, indicating that continued use of the affected devices carries a reasonable probability of causing serious adverse health consequences or death.
The recall was initiated by Medtronic on May 22, 2026, with urgent notifications sent to healthcare providers on May 28, 2026. The FDA officially posted and classified the recall in early July 2026. Approximately 1,881 devices distributed worldwide are affected, including units supplied in the United States, India, Canada, Australia, Japan, several European countries, and other international markets.
Healthcare facilities have been instructed to immediately review their inventories, identify the affected lot numbers, quarantine any unused devices, and return them to Medtronic for replacement or credit. Hospitals are also advised to notify all implanting physicians and clinical teams about the recall and ensure that any redistributed products are traced and removed from use.
Importantly, the recall applies only to specific Harmony Delivery Catheter Systems from affected manufacturing lots and does not apply to patients who have already undergone successful implantation of a Harmony Transcatheter Pulmonary Valve. The issue relates to the delivery device used during the implantation procedure rather than the implanted valve itself.
The FDA continues to monitor the recall as part of its medical device safety program and has advised healthcare providers to follow Medtronic's recall instructions closely. The agency encourages prompt reporting of any adverse events or device-related problems through its medical device reporting system to help protect patient safety.
